These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25994197)

  • 1. Clinicoradiological outcomes of 33 cases of surgically resected pulmonary pleomorphic carcinoma: correlation with prognostic indicators.
    Nishida A; Abiru H; Hayashi H; Uetani M; Matsumoto K; Tsuchiya T; Yamasaki N; Nagayasu T; Hayashi T; Kinoshita N; Honda S; Ashizawa K
    Eur Radiol; 2016 Jan; 26(1):25-31. PubMed ID: 25994197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary sarcomatoid carcinoma: an analysis of a rare cancer from the Surveillance, Epidemiology, and End Results database.
    Rahouma M; Kamel M; Narula N; Nasar A; Harrison S; Lee B; Stiles B; Altorki NK; Port JL
    Eur J Cardiothorac Surg; 2018 Apr; 53(4):828-834. PubMed ID: 29240878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological characteristics of surgically resected pulmonary pleomorphic carcinoma.
    Chen F; Sonobe M; Sato T; Sakai H; Huang CL; Bando T; Date H
    Eur J Cardiothorac Surg; 2012 May; 41(5):1037-42. PubMed ID: 22228848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and prognosis of clinical N0 non-small cell lung cancer exceeding 30 mm.
    Kagimoto A; Tsutani Y; Handa Y; Mimae T; Miyata Y; Okada M
    Jpn J Clin Oncol; 2020 Oct; 50(11):1306-1312. PubMed ID: 32901276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiological classification of multiple lung cancers and the prognostic impact based on the presence of a ground glass opacity component on thin-section computed tomography.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    Lung Cancer; 2017 Nov; 113():7-13. PubMed ID: 29110852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved.
    Matsunaga T; Suzuki K; Takamochi K; Oh S
    Eur J Cardiothorac Surg; 2014 Jul; 46(1):86-91. PubMed ID: 24321998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgically resected sarcomatoid carcinoma of the lung: a nationwide retrospective study in 2010.
    Kaseda K; Asakura K; Shintani Y; Okami J; Toyooka S; Sato Y; Watanabe SI; Chida M; Suzuki H; Miyaoka E; Yoshino I; Date H;
    BMC Cancer; 2024 Aug; 24(1):938. PubMed ID: 39095716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological Analysis of 17 Surgically Resected Pulmonary Pleomorphic Carcinoma Cases.
    Iijima Y; Nakajima Y; Kinoshita H; Nishimura Y; Iizuka T; Akiyama H; Hirata T
    Ann Thorac Cardiovasc Surg; 2021 Feb; 27(1):1-9. PubMed ID: 32493871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T4 extension alone is more predictive of better survival than a tumour size >7 cm for resected T4N0-1M0 non-small-cell lung cancer†.
    Li Q; Zhang P; Wang Y; Liu D; Luo L; Diasio RB; Yang P; Jiang G
    Eur J Cardiothorac Surg; 2019 Apr; 55(4):682-690. PubMed ID: 30508081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Node-negative non-small cell lung cancer: pathological staging and survival in 1765 consecutive cases.
    Robinson BM; Kennedy C; McLean J; McCaughan BC
    J Thorac Oncol; 2011 Oct; 6(10):1691-6. PubMed ID: 21869717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes?
    Kudo Y; Saji H; Shimada Y; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Eur J Cardiothorac Surg; 2012 Sep; 42(3):414-9. PubMed ID: 22398463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-station skip-N2 disease: good prognosis in resected non-small-cell lung cancer (long-term results in skip-N2 disease).
    Yazgan S; Ucvet A; Gursoy S; Samancilar O; Yagci T
    Interact Cardiovasc Thorac Surg; 2019 Feb; 28(2):247-252. PubMed ID: 30085065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of ground-glass areas within tumours in non-small-cell lung cancer.
    Sakurai H; Goto Y; Yoh K; Takamochi K; Shukuya T; Hishida T; Tsuboi M; Yoshida K; Ohde Y; Okumura S; Taguri M; Kunitoh H
    Eur J Cardiothorac Surg; 2024 Mar; 65(4):. PubMed ID: 38598462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic predictors in non-small cell lung cancer patients undergoing intentional segmentectomy.
    Koike T; Koike T; Yamato Y; Yoshiya K; Toyabe S
    Ann Thorac Surg; 2012 Jun; 93(6):1788-94. PubMed ID: 22560265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of combined pulmonary fibrosis and emphysema in patients with resected non-small-cell lung cancer: a retrospective cohort study.
    Kumagai S; Marumo S; Yamanashi K; Tokuno J; Ueda Y; Shoji T; Nishimura T; Huang CL; Fukui M
    Eur J Cardiothorac Surg; 2014 Dec; 46(6):e113-9. PubMed ID: 25345566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of volume-based 18F-FDG PET/CT parameter in patients with surgically resected non-small cell lung cancer. Comparison with immunohistochemical biomarkers.
    Lee JY; Choi JY; Heo JH; Han J; Jang SJ; Kim K; Kim J; Shim YM; Kim BT
    Nuklearmedizin; 2016; 55(1):7-14. PubMed ID: 26875430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of a ground glass opacity component in the clinical T classification of non-small cell lung cancer.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    J Thorac Cardiovasc Surg; 2017 Dec; 154(6):2102-2110.e1. PubMed ID: 28947198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease.
    Tsutani Y; Mimura T; Kai Y; Ito M; Misumi K; Miyata Y; Okada M
    J Thorac Cardiovasc Surg; 2017 Sep; 154(3):1089-1096.e1. PubMed ID: 28483268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.